Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul S Larson

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The Lancet. Neurology|April 5, 2008
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trialWilliam J Marks, Jill L Ostrem, Leonard Verhagen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 21, 2014
Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deploymentMatthew T Silvestrini, Dali Yin, Alastair J Martin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 21, 2025
Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's DiseaseAmber D Van Laar, Chadwick W Christine, Nicolás Phielipp, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 2020
Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's diseaseR Mark Richardson, Krystof S Bankiewicz, Chadwick W Christine, et al.
Human Brain Mapping|December 25, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Annals of Neurology|January 29, 2015
Differential effects of deep brain stimulation target on motor subtypes in Parkinson's diseaseMaya Katz, Marta San Luciano, Kimberly Carlson, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2020
Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJohn G Nutt, Carolin Curtze, Amie Hiller, et al.
Stereotactic and Functional Neurosurgery|April 16, 2011
Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brainR Mark Richardson, Adrian P Kells, Alastair J Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 24, 2011
Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's diseaseR Mark Richardson, Adrian P Kells, Kathryn H Rosenbluth, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The Lancet. Neurology|April 5, 2008
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trialWilliam J Marks, Jill L Ostrem, Leonard Verhagen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 21, 2014
Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deploymentMatthew T Silvestrini, Dali Yin, Alastair J Martin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 21, 2025
Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's DiseaseAmber D Van Laar, Chadwick W Christine, Nicolás Phielipp, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 2020
Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's diseaseR Mark Richardson, Krystof S Bankiewicz, Chadwick W Christine, et al.
Human Brain Mapping|December 25, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Annals of Neurology|January 29, 2015
Differential effects of deep brain stimulation target on motor subtypes in Parkinson's diseaseMaya Katz, Marta San Luciano, Kimberly Carlson, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Therapeutic DBS for OCD Suppresses the Default Mode NetworkNatalya Slepneva, Genevieve Basich-Pease, Lee Reid, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2020
Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJohn G Nutt, Carolin Curtze, Amie Hiller, et al.
Stereotactic and Functional Neurosurgery|April 16, 2011
Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brainR Mark Richardson, Adrian P Kells, Alastair J Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 24, 2011
Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's diseaseR Mark Richardson, Adrian P Kells, Kathryn H Rosenbluth, et al.
Pageof 9